BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease
Search BioPortfolio:       

A Tip for Better Pipetting: P2i surface enhancements for pipette tips reduce retention and open up other functional capabilities.

July 18th 2005: Porton Down, UK –P2i Limited has developed a coating technology that will radically increase the effectiveness and flexibility of pipetting. Using its proprietary cold plasma-enhanced chemical vapour deposition (PECVD) process, P2i can apply nano-thin coatings to pipette tips; this dramatically enhances their performance, virtually eliminating liquid retention. P2i-enhanced pipette tips produce more accurate and reliable results and can reduce reagent costs by up to 10%. The ultra-low adhesion, pin-hole free coating has a surface energy 3x lower than Teflon® (PTFE) and has no leachable components.


High resolution images available on request from neilr@alto-marketing.com

According to P2i’s CEO, Quentin Compton-Bishop, “Pipetting is an important, routine process in proteomics and drug discovery where thousands of tiny samples have to be analysed. When measuring small volumes the slightest sample loss can cause downstream problems. By using our new coating process almost all of the sample can be expelled, enabling more reliable results. Moreover, when sample drugs and reagents can cost thousands of dollars per gram, reducing retention and waste will help save laboratories money.”

P2i’s cold plasma process can be used to create a variety of other surface modifications which could increase the flexibility of pipetting. Mr Compton-Bishop commented, “Our process can be used to deposit a range of functional groups on both plastic and glass surfaces, besides the ultra low surface energy enhancement which produces the low retention effect. For example, we can create hydrophilic surfaces and other specific reaction sites for proteins.”

Moreover, there is also the potential to give the inner and outer surfaces of pipette tips different surface coatings, further expanding the possibilities. Once modified using the plasma process, pipette tips can be gamma irradiated as required to make them suitable for sterile techniques.

P2i’s patented plasma process was originally developed by the UK Defence Science and Technology Laboratory (Dstl) in collaboration with the University of Durham, to protect the armed forces against chemical attacks by enhancing uniforms and equipment with super-repellent coatings. The coating technology is now proving ideal for pipette tips, medical textiles, filters, microplates, and instrumentation. Using plasma or ‘ionised gas’, proprietary chemicals can be deposited in layers only molecules thick over any surface. The polymerised compounds bind at the molecular level creating an invisible layer that does not leach. The super liquid-repellent coating for example, has a 3x lower surface energy than the benchmark Teflon® (PTFE) and unlike other hydrophobic treatments, it is also able to repel 100% isopropylalcohol (IPA) and oils.

The specialised plasma chambers used for the plasma treatments are robust and can be scaled to fit the process. P2i’s onsite facilities include 40-litre, 300-litre and 2000-litre chambers, supported by the expertise of its team of plasma process chemists. Mr Compton-Bishop commented, “Our range of chambers can process single-use disposable products as small as frits and pipette tips in their thousands through to larger items such as whole medical devices and protective apparel. For high level users, however, we can install bespoke chambers at customer sites under licence.”

www.p2ilabs.com

-ENDS-

Notes for editors:

P2i

P2i Ltd. was established in 2004 to commercialise super liquid-repellent treatments developed by the Defence Science and Technology Laboratory (Dstl) (www.dstl.gov.uk) and the University of Durham (www.durham.ac.uk). P2i is the exclusive licensee of Dstl’s patents and is a joint venture between Dstl and Porton Capital, a venture firm specialising in civilian applications of military research and technology (www.portoncapital.com). P2i’s plasma technology enables it to deposit materials in layers only molecules thick over the whole surface of a product by means of an ionised gas or “plasma”. This enables the surfaces of the product to be enhanced with a super oleophobic (oil repellent) and hydrophobic (water-repellent) treatment while leaving the other properties of the product unchanged. So, for example, outdoor wear will have every inch of fabric, zipper and seam protected while leaving the pores of the fabric as open and breathable as they were before and without affecting the feel or drape of the material. Now on a commercial scale, P2i’s enhancement process can be applied to a wide range of products in the textiles, medical, pharmaceutical, electronics and homeland security markets. P2i has the capability also to produce a range of other surface effects, such as hydrophilic, antistatic and fire retardant.

Dstl

Dstl (the Defence Science and Technology Laboratory) is the centre of scientific excellence for the UK Ministry of Defence, housing one of the largest groups of scientists and engineers in public service in the country. Its 3,000 strong workforce includes some of the nation’s most talented and creative scientists with the brief to ensure that the UK Armed Forces and Government are supported by world class scientific advice. Dstl delivers defence research, specialist technical services and the ability to track global technological developments. Its capabilities compare with the best in the world, supporting procurement decisions, defence policy making and operations. For more information visit www.dstl.gov.uk


---ENDS---

Product enquiries
P2i Limited – Quentin Compton-Bishop, CEO
t: 44 (0)1980-556493 e: info@p2ilabs.com 

Media enquiries
Alto Marketing Limited – Neil Ravenhill
t: +44 (0)1489 557672 e : neilr@alto-marketing.com

 

 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.  See User Agreement

Send comments and feedback to:
Peter Barfoot Managing Director, BioPortfolio Ltd.
UK Tel: (+44) 1300 321501
USA Voicemail and Fax: (+1) 415 680 2472

All rights reserved. All other trademarks recognized.

BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10

Copyright © 1997-2008 - BioPortfolio Limited.